MCL1 and glioblastoma: While the expression of Bcl-2 and Bcl-xL was reduced by the combination treatment in ULM-GBM-PC128 and ULM-GBM-SC40 cells, the most consistent finding was an increased Noxa/Mcl-1 ratio (Figure 4a).